BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10361884)

  • 1. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
    Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
    Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological properties of naftopidil, a drug for treatment of the bladder outlet obstruction for patients with benign prostatic hyperplasia].
    Ikegaki I
    Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):63-9. PubMed ID: 10976457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular alpha1-adrenoceptor subtype selectivity and alpha1-blocker-induced orthostatic hypotension.
    Take H; Shibata K; Awaji T; Hirasawa A; Ikegaki I; Asano T; Takada T; Tsujimoto G
    Jpn J Pharmacol; 1998 May; 77(1):61-70. PubMed ID: 9639061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
    Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
    Kenny BA; Naylor AM; Carter AJ; Read AM; Greengrass PM; Wyllie MG
    Urology; 1994 Jul; 44(1):52-7. PubMed ID: 7913781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    Noguchi Y; Ohtake A; Suzuki M; Sasamata M
    Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
    Murata S; Taniguchi T; Muramatsu I
    Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
    Muramatsu I; Taniguchi T; Okada K
    Jpn J Pharmacol; 1998 Nov; 78(3):331-5. PubMed ID: 9869267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy.
    Yamada S; Suzuki M; Kato Y; Kimura R; Mori R; Matsumoto K; Maruyama M; Kawabe K
    Life Sci; 1992; 50(2):127-35. PubMed ID: 1370569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates.
    Takahashi M; Taniguchi T; Kanamaru H; Okada K; Muramatsu I
    Life Sci; 2000 Oct; 67(20):2443-51. PubMed ID: 11065167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human alpha1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways.
    Taguchi K; Yang M; Goepel M; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):100-10. PubMed ID: 9521482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors.
    Proudman RGW; Pupo AS; Baker JG
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00602. PubMed ID: 32608144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
    Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
    Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
    Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
    Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
    Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
    J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftopidil, a new adrenoceptor blocking agent with Ca(2+)-antagonistic properties: interaction with adrenoceptors.
    Sponer G; Borbe HO; Müller-Beckmann B; Freud P; Jakob B
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):1006-13. PubMed ID: 1282583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.